UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 143

Sortiert nach

Real‐world efficacy, tolerability, and safety of ubrogepant

Headache, 2021-04, Vol.61 (4), p.620-627

2021

Volltextzugriff (PDF)

Safety and efficacy of high-dose melphalan and auto-SCT in patients with AL amyloidosis and cardiac involvement

Bone marrow transplantation (Basingstoke), 2014-03, Vol.49 (3), p.434-439

2014

Volltextzugriff (PDF)

Granulocyte transfusions in severe aplastic anemia: an eleven-year experience

Haematologica (Roma), 2009-12, Vol.94 (12), p.1661-1668

2009

Volltextzugriff (PDF)

The incidence of atrial fibrillation among patients with AL amyloidosis undergoing high-dose melphalan and stem cell transplantation: experience at a single institution

Bone marrow transplantation (Basingstoke), 2017-09, Vol.52 (9), p.1349-1351

2017

Volltextzugriff (PDF)

Effect of severe hypoalbuminemia on toxicity of high-dose melphalan and autologous stem cell transplantation in patients with AL amyloidosis

Bone marrow transplantation (Basingstoke), 2016-10, Vol.51 (10), p.1318-1322

2016

Volltextzugriff (PDF)

Neuralgic amyotrophy following high-dose melphalan and autologous peripheral blood stem cell transplantation for AL amyloidosis

Bone marrow transplantation (Basingstoke), 2018-03, Vol.53 (3), p.371-373

2018

Volltextzugriff (PDF)

Ruxolitinib Cream in the Treatment of Cutaneous Lichen Planus: A Prospective, Open-Label Study

Journal of investigative dermatology, 2022-08, Vol.142 (8), p.2109-2116.e4

2022

Volltextzugriff (PDF)

Strategies for improving colorectal cancer detection with routine computed tomography

Abdominal radiology (New York), 2023-06, Vol.48 (6), p.1891-1899

2023

Volltextzugriff (PDF)

High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial

Bone marrow transplantation (Basingstoke), 2004-02, Vol.33 (4), p.381-388

2004

Volltextzugriff (PDF)

Hospital admissions following outpatient administration of high-dose melphalan and autologous SCT for AL amyloidosis

Bone marrow transplantation (Basingstoke), 2014-10, Vol.49 (10), p.1345-1346

2014

Volltextzugriff (PDF)

Tandem cycles of high-dose melphalan and autologous stem cell transplantation increases the response rate in AL amyloidosis

Bone marrow transplantation (Basingstoke), 2007-09, Vol.40 (6), p.557-562

2007

Volltextzugriff (PDF)

Using neutrophil and lymphocyte VCS indices in ambulatory pediatric patients presenting with fever

International journal of laboratory hematology, 2010-08, Vol.32 (4), p.449-451

2010

Volltextzugriff (PDF)

A second course of high-dose melphalan and auto-SCT for the treatment of relapsed AL amyloidosis

Bone marrow transplantation (Basingstoke), 2011-07, Vol.46 (7), p.976-980

2011

Volltextzugriff (PDF)

Utility of hematologic and volume, conductivity, and scatter parameters from umbilical cord blood in predicting chorioamnionitis

International journal of laboratory hematology, 2010-06, Vol.32 (3), p.351-359

2010

Volltextzugriff (PDF)

Clinical and molecular characteristics of patients with non-amyloid light chain deposition disorders, and outcome following treatment with high-dose melphalan and autologous stem cell transplantation

Bone marrow transplantation (Basingstoke), 2006-09, Vol.38 (5), p.339-343

2006

Volltextzugriff (PDF)

Long-term outcome of patients with monoclonal Ig deposition disease treated with high-dose melphalan and stem cell transplantation

Bone marrow transplantation (Basingstoke), 2011-01, Vol.46 (1), p.161-162

2011

Volltextzugriff (PDF)

Hypotensive Transfusion Reactions in Patients Taking Angiotensin-Converting–Enzyme Inhibitors

The New England journal of medicine, 2000-11, Vol.343 (19), p.1422-1423

Quillen, Karen

2000

Volltextzugriff (PDF)

An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis

Bone marrow transplantation (Basingstoke), 2001-10, Vol.28 (7), p.637-642

2001

Volltextzugriff (PDF)

Performance characteristics of two automated solid-phase red cell adherence systems for pretransfusion antibody screening: a cautionary tale

Immunohematology, 2012-01, Vol.28 (4), p.137

2012

Volltextzugriff (PDF)

Racial/Ethnic Disparities in Dermatology Research Fellowship Funding

Journal of racial and ethnic health disparities, 2023-08

2023

Volltextzugriff (PDF)

Impact of timing of preoperative gabapentin administration on postoperative somnolence

Journal of Osteopathic Medicine (Online), 2022-02, Vol.122 (6), p.303-311

2022

Volltextzugriff (PDF)

Diatom-based paleolimnological reconstruction of regional climate and local land-use change from a protected sinkhole lake in southern Florida, USA

Journal of paleolimnology, 2013, Vol.49 (1), p.15-30

2013

Volltextzugriff (PDF)

Predictive factors for hematopoietic engraftment after autologous peripheral blood stem cell transplantation for AL amyloidosis

Bone marrow transplantation (Basingstoke), 2005-03, Vol.35 (6), p.567-575

2005

Volltextzugriff (PDF)

High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study

Annals of internal medicine, 2004-01, Vol.140 (2), p.85

2004

Volltextzugriff (PDF)

Tandem cycles of high-dose melphalan and autologous stem cell transplantation increases the response rate in AL amyloidosis

Bone marrow transplantation (Basingstoke), 2007-09, Vol.40 (6), p.607-607

2007

Volltextzugriff (PDF)

1 – 25 von 143

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(124)
Mit Volltextzugriff
(127)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(143)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Real‐world efficacy, tolerability, and safety of ubrogepant

Safety and efficacy of high-dose melphalan and auto-SCT in patients with AL amyloidosis and cardiac involvement

Granulocyte transfusions in severe aplastic anemia: an eleven-year experience

The incidence of atrial fibrillation among patients with AL amyloidosis undergoing high-dose melphalan and stem cell transplantation: experience at a single institution

Effect of severe hypoalbuminemia on toxicity of high-dose melphalan and autologous stem cell transplantation in patients with AL amyloidosis

Neuralgic amyotrophy following high-dose melphalan and autologous peripheral blood stem cell transplantation for AL amyloidosis

Ruxolitinib Cream in the Treatment of Cutaneous Lichen Planus: A Prospective, Open-Label Study

Strategies for improving colorectal cancer detection with routine computed tomography

High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial

Hospital admissions following outpatient administration of high-dose melphalan and autologous SCT for AL amyloidosis

Tandem cycles of high-dose melphalan and autologous stem cell transplantation increases the response rate in AL amyloidosis

Using neutrophil and lymphocyte VCS indices in ambulatory pediatric patients presenting with fever

A second course of high-dose melphalan and auto-SCT for the treatment of relapsed AL amyloidosis

Utility of hematologic and volume, conductivity, and scatter parameters from umbilical cord blood in predicting chorioamnionitis

Clinical and molecular characteristics of patients with non-amyloid light chain deposition disorders, and outcome following treatment with high-dose melphalan and autologous stem cell transplantation

Long-term outcome of patients with monoclonal Ig deposition disease treated with high-dose melphalan and stem cell transplantation

Hypotensive Transfusion Reactions in Patients Taking Angiotensin-Converting–Enzyme Inhibitors

An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis

Performance characteristics of two automated solid-phase red cell adherence systems for pretransfusion antibody screening: a cautionary tale

Racial/Ethnic Disparities in Dermatology Research Fellowship Funding

Impact of timing of preoperative gabapentin administration on postoperative somnolence

Diatom-based paleolimnological reconstruction of regional climate and local land-use change from a protected sinkhole lake in southern Florida, USA

Predictive factors for hematopoietic engraftment after autologous peripheral blood stem cell transplantation for AL amyloidosis

High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study

Tandem cycles of high-dose melphalan and autologous stem cell transplantation increases the response rate in AL amyloidosis

Suchergebnisse filtern